Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

SHE:300049 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,463	1,342	1,147	1,001	891.56	800.96
Other Revenue	7.49	7.49	6.9	7.37	6.93	6.57
Revenue	1,470	1,349	1,154	1,009	898.48	807.53
Revenue Growth (YoY)	10.82%	16.93%	14.37%	12.27%	11.26%	-2.91%
Cost of Revenue	392.88	350.73	291.39	267.67	239.14	226.65
Gross Profit	1,077	998.28	862.34	741.09	659.34	580.88
Selling, General & Admin	601.96	584.24	527.56	474.49	405.7	361.47
Research & Development	107.84	99.49	82.47	70.82	64.79	65.82
Other Operating Expenses	8.86	8.08	10.43	10.79	12.5	11.39
Operating Expenses	741.29	711.59	622	562.68	491.94	440.51
Operating Income	336.02	286.69	240.34	178.41	167.4	140.38
Interest Expense	-3.16	-2.77	-0.9	-1.58	-2.33	-3.21
Interest & Investment Income	12.77	16.07	12.38	9.73	10.54	3.41
Currency Exchange Gain (Loss)	10.37	10.37	-2.31	7.93	16.48	-12.48
Other Non Operating Income (Expenses)	-31.27	-2.03	4.08	-1.28	-0.26	-0.25
EBT Excluding Unusual Items	324.74	308.34	253.59	193.21	191.83	127.84
Impairment of Goodwill	-7.7	-7.7	-	-	-	-
Gain (Loss) on Sale of Investments	-26.88	-23.11	-	-	-	-1.6
Gain (Loss) on Sale of Assets	0.31	-0.31	-0.82	-1.86	-3.46	-6.93
Asset Writedown	-0.33	-0	-4.71	-0	-	-
Other Unusual Items	-6.66	-6.66	-12.66	0.29	0.77	-5.32
Pretax Income	283.48	270.55	235.4	191.63	189.14	113.99
Income Tax Expense	84.76	74.67	58.29	46.22	41.1	23.72
Earnings From Continuing Operations	198.72	195.88	177.11	145.41	148.04	90.27
Minority Interest in Earnings	-75.55	-82.59	-75.55	-47.52	-52.57	-28.36
Net Income	123.17	113.29	101.56	97.89	95.47	61.91
Net Income to Common	123.17	113.29	101.56	97.89	95.47	61.91
Net Income Growth	-5.55%	11.54%	3.75%	2.54%	54.22%	42.69%
Shares Outstanding (Basic)	262	264	263	263	260	256
Shares Outstanding (Diluted)	262	264	263	263	260	256
Shares Change (YoY)	-1.18%	0.50%	-0.01%	1.30%	1.31%	0.03%
EPS (Basic)	0.47	0.43	0.39	0.37	0.37	0.24
EPS (Diluted)	0.47	0.43	0.39	0.37	0.37	0.24
EPS Growth	-4.42%	10.98%	3.76%	1.22%	52.22%	42.65%
Free Cash Flow	99.3	2.44	115.66	98.69	142.94	90.41
Free Cash Flow Per Share	0.38	0.01	0.44	0.38	0.55	0.35
Dividend Per Share	-	-	-	0.200	-	-
Gross Margin	73.28%	74.00%	74.74%	73.47%	73.38%	71.93%
Operating Margin	22.86%	21.25%	20.83%	17.69%	18.63%	17.38%
Profit Margin	8.38%	8.40%	8.80%	9.70%	10.63%	7.67%
Free Cash Flow Margin	6.75%	0.18%	10.03%	9.78%	15.91%	11.20%
EBITDA	411.97	358.88	307.52	236.39	221.12	209.72
EBITDA Margin	28.02%	26.60%	26.65%	23.43%	24.61%	25.97%
D&A For EBITDA	75.95	72.19	67.18	57.98	53.71	69.35
EBIT	336.02	286.69	240.34	178.41	167.4	140.38
EBIT Margin	22.86%	21.25%	20.83%	17.69%	18.63%	17.38%
Effective Tax Rate	29.90%	27.60%	24.76%	24.12%	21.73%	20.81%
Revenue as Reported	1,470	1,349	1,154	1,009	898.48	807.53
Advertising Expenses	-	3.34	4.76	9.83	9.3	5.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.